SMTL ID : 9n9l.1 (1 other biounit)

An RORgt Inverse agonist for treatment of Psoriasis

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.64 Å

Oligo State

monomer

Ligands

1 x 01: (5P)-5-[2,3-dichloro-4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl]-N-(2-hydroxy-2-methylpropyl)-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide

01.1: 25 residues within 4Å: Chain A: Q.22, L.23, W.53, C.56, H.59, L.60, A.63, M.94, V.97, L.98, M.101, A.104, V.112, F.113, F.114, F.124, L.127, C.129, L.132, I.133, I.136, H.215, R.218, L.219, F.222 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:L.23, A:L.60, A:F.124, A:I.133, A:I.136 Hydrogen bonds: A:H.215 Water bridges: A:Q.22, A:Q.22

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kinzel, O. et al., Identification of JNJ-61803534, a ROR gamma t Inverse Agonist for the Treatment of Psoriasis. J.Med.Chem. (2025)

Release Date

2025-04-30

Peptides

Nuclear receptor ROR-gamma: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Nuclear receptor ROR-gamma

Related Entries With Identical Sequence